Preparation and investigation of Ulex europaeus agglutinin I-conjugated liposomes as potential oral vaccine carriers

Archives of Pharmacal Research

Volumn 34, Issue 11, 2011, Pages 1899-1907

  Li, Kexin ^a   Chen, Dawei ^a   Zhao, Xiuli ^a   Hu, Haiyang ^a   Yang, Chunrong ^a   Pang, Dahai ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Shenyang Food and Drug Administration   (China)

Author keywords

Bovine serum albumin; Liposomes; Oral vaccine; Ulex europaeus agglutinin I

Indexed keywords

ALBUMIN CONJUGATE; BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIPOSOME; ORAL VACCINE; ULEX EUROPAEUS AGGLUTININ; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; ENCAPSULATION; FEMALE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO CULTURE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; ORAL VACCINE CARRIER;

ADMINISTRATION, ORAL; ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; FEASIBILITY STUDIES; FEMALE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED STRAINS; PHYSICOCHEMICAL PHENOMENA; PLANT LECTINS; SERUM ALBUMIN, BOVINE; SPECIFIC PATHOGEN-FREE ORGANISMS; SUSPENSIONS; ULEX; UNILAMELLAR LIPOSOMES; VACCINES;

EID: 83655197404     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-1110-3     Document Type: Article

References (24)

1. Y. Aramaki H. Tomizawa T. Hara K. Yachi H. Kikuchi S. Tsuchiya 1993 Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administration Pharm. Res. 10 1228 1231 8415412 10.1023/A:1018936806278 1:CAS:528:DyaK3sXmtlertr0%3D (Pubitemid 23244182)
2. H. Bakowsky T. Richter C. Kneuer D. Hoekstra U. Rothe G. Bendas C. Ehrhardt U. Bakowsky 2008 Adhesion characteristics and stability assessment of lectin-modified liposomes for site-specific drug delivery Biochim. Biophys. Acta 1778 242 249 17964278 10.1016/j.bbamem.2007.09.033 1:CAS:528: DC%2BD1cXptlGhtg%3D%3D
3. E. Balasse J. Odot G. Gatouillat M. C. Andry C. Madoulet 2008 Enhanced immune response induced by BSA loaded in hydroxyethylstarch microparticles Int. J. Pharm. 353 131 138 18162346 10.1016/j.ijpharm.2007.11.021 1:CAS:528:DC%2BD1cXivFKjuro%3D
4. G. Bendas A. Krause U. Bakowsky J. Vogel U. Rothe 1999 Targetability of novel immunoliposomes prepared by a new antibody conjugation technique Int. J. Pharm. 181 79 93 10370205 10.1016/S0378-5173(99)00002-2 1:CAS:528: DyaK1MXjslGqurk%3D (Pubitemid 29199890)
5. N. K. Childers S. M. Michalek D. G. Pritchard J. R. McGhee 1990 Mucosal and systemic responses to an oral liposome-Streptococcus mutans carbohydrate vaccine in humans Reg. Immunol. 3 289 296 2132755
6. M. A. Clark M. A. Jepson N. L. Simmons T. A. Booth B. H. Hirst 1993 Differential expression of lectin-binding sites defines mouse intestinal M-cells J. Histochem. Cytochem. 41 1679 1687 7691933 10.1177/41.11.7691933 1:CAS:528:DyaK3sXms1Oht7g%3D (Pubitemid 23317114)
7. C. Dai B. Wang H. Zhao B. Li 2005 Factors affecting protein release from microcapsule prepared by liposome in alginate Colloids Surf. B Biointerfaces 42 253 258 15893226 10.1016/j.colsurfb.2004.12.020 1:CAS:528:DC%2BD2MXktVOjsrg%3D (Pubitemid 40693983)
8. A. des Rieux V. Fievez M. Garinot Y. J. Schneider V. Préat 2006 Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach J. Control. Release 116 1 27 17050027 10.1016/j.jconrel. 2006.08.013 (Pubitemid 44792295)
9. I. Ezpeleta M. A. Arangoa J. M. Irache S. Stainmesse C. Chabenat Y. Popineau A. M. Orecchioni 1999 Preparation of Ulex europaeus lectin-gliadin nanoparticle conjugates and their interaction with gastrointestinal mucus Int. J. Pharm. 191 25 32 10556737 10.1016/S0378-5173(99)00232-X 1:CAS:528: DyaK1MXotVGjs7g%3D (Pubitemid 29502174)
10. P. J. Giannasca K. T. Giannasca P. Falk J. I. Gordon M. R. Neutra 1994 Regional differences in glycoconjugates of intestinal M cells in mice: potential targets for mucosal vaccines Am. J. Physiol. 267 G1108 G1121 7810658 1:CAS:528:DyaK2MXivFKntbo%3D
11. P. N. Gupta S. Mahor A. Rawat K. Khatri A. Goyal S. P. Vyas 2006 Lectin anchored stabilized biodegradable nanoparticles for oral immunization 1. Development and in vitro evaluation Int. J. Pharm. 318 163 173 16621367 10.1016/j.ijpharm.2006.03.017 1:CAS:528:DC%2BD28XmsVGltr8%3D (Pubitemid 43963301)
12. J. M. Irache C. Durrer D. Duchêne G. Ponchel 1994 Preparation and characterization of lectin-latex conjugates for specific bioadhesion Biomaterials 15 899 904 7833437 10.1016/0142-9612(94)90114-7 1:CAS:528:DyaK2cXmtlygsr0%3D (Pubitemid 24284378)
13. T. Irie S. Watarai H. Kodama 2003 Humoral immune response of carp (Cyprinus carpio) induced by oral immunization with liposome-entrapped antigen Dev. Comp. Immunol. 27 413 421 12631523 10.1016/S0145-305X(02)00137-4 1:CAS:528:DC%2BD3sXhvFSls7k%3D (Pubitemid 36288453)
14. K. S. Jaganathan S. P. Vyas 2006 Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally Vaccine 24 4201 4211 16446012 10.1016/j.vaccine.2006.01.011 1:CAS:528:DC%2BD28XksFejs7w%3D
15. E. C. Lavellea S. Sharif 1995 The importance of gastrointestinal uptake of particles in the design of oral delivery systems Adv. Drug Deliv. Rev. 18 5 22 10.1016/0169-409X(95)00048-C
16. J. R. McGhee H. Kiyono 1993 New perspectives in vaccine development: mucosal immunity to infections Infect. Agents Dis. 2 55 73 8162356 1:STN:280:DyaK2c3hsVyrsw%3D%3D (Pubitemid 23252451)
17. S. M. Michalek N. K. Childers J. Katz F. R. Denys A. K. Berry J. H. Eldridge J. R. McGhee R. Curtiss 3rd 1989 Liposomes as oral adjuvants Curr. Top. Microbiol. Immunol. 146 51 58 2659275 1:STN:280:DyaL1M3nsFylsQ%3D%3D
18. S. Minato K. Iwanaga M. Kakemi S. Yamashita N. Oku 2003 Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: effect of lipid dose on systemic and mucosal immunity J. Control. Release 89 189 197 12711443 10.1016/S0168-3659(03)00093-2 1:CAS:528:DC%2BD3sXjtVegtbc%3D (Pubitemid 36511428)
19. D. T. O'Hagan 1992 Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations Clin. Pharmacokinet. 22 1 10 1559304 10.2165/00003088-199222010-00001
20. H. Sah R. Toddywala Y. W. Chien 1995 Continuous release of proteins from biodegradable microcapsules and in vivo evaluation of their potential as a vaccine adjuvant J. Control. Release 35 137 144 10.1016/0168-3659(95)00029-8 1:CAS:528:DyaK2MXnsFWls74%3D
21. D. Wachsmann J. P. Klein M. Schöller R. M. Frank 1985 Local and systemic immune response to orally administered liposome-associated soluble S. mutans cell wall antigens Immunology 54 189 193 3972433 1:CAS:528: DyaL2MXosVaqsQ%3D%3D (Pubitemid 15158919)
22. Y. Wang X. Wang G. Luo Y. Dai 2008 Adsorption of bovin serum albumin (BSA) onto the magnetic chitosan nanoparticles prepared by a microemulsion system Bioresour. Technol. 99 3881 3884 17892932 10.1016/j.biortech.2007.08.017 1:CAS:528:DC%2BD1cXitlyqu74%3D (Pubitemid 351754888)
23. L. Xing C. Dawei X. Liping Z. Rongqing 2003 Oral colonspecific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome J. Control. Release 93 293 300 14644579 10.1016/j.jconrel.2003.08.019 (Pubitemid 37485951)
24. T. Zor Z. Selinger 1996 Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies Anal. Biochem. 236 302 308 8660509 10.1006/abio.1996.0171 1:CAS:528:DyaK28Xislaju7w%3D (Pubitemid 26136110)